相关实验视频

Updated: May 22, 2025

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
10:29

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

Published on: November 12, 2010

39.5K

超磁刺激在自杀倾向中的有效性:最新的系统性审查

Manuele S J1, Cerins A1, Jenkins L M1,2

  • 1Department of Psychiatry, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.

medRxiv : the preprint server for health sciences
|May 19, 2025
PubMed
概括

重复的横磁刺激 (rTMS) 显示出减少自杀思想和行为 (STB) 的承诺. 应用在前额叶皮层的高频rTMS和间歇性theta爆发刺激 (iTBS) 似乎是最有效和安全的.

更多相关视频

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.8K
Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil09:30

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil

Published on: October 4, 2016

22.2K

相关概念视频

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
21